DAKT
Daktronics, Inc.
$18.61
+2.20% 2026-10-19
Technology
DAKTSPY
1W
+2.0%
1M
+6.9%
3M
-4.4%
6M
-4.2%
YTD
-5.9%
1Y
-4.8%
Grades vs sector
Momentumno data–
Momentum
no data
Percentile within its GICS sector across the S&P 1500.
Growthno data–
Growth
no data
Percentile within its GICS sector across the S&P 1500.
Valueno data–
Value
no data
Percentile within its GICS sector across the S&P 1500.
Profitabilityno data–
Profitability
no data
Percentile within its GICS sector across the S&P 1500.
Revisionsno data–
Revisions
no data
30-day change in analysts' current-year EPS estimate; graded across covered stocks.
Our models
Not held by any of our 3 live models right now.
Momentum Top 15
not ranked (outside this model's universe or screens)
Quality Growthnot ranked (outside this model's universe or screens)
Momentum Blendnot in the current book
Key stats
Market cap$895.0M
P/E (trailing)19.0
P/E (forward)11.8
52-week range16.77 – 28.27
Revenue growth (YoY, latest qtr)+7.1%
Dividend yield0.00%
Analyst consensusStrong Buy (3)
Mean price target$33.67 (+81%)
Valuation & fundamentals
Bottom line
Roughly fairly valued
Model read-out from the numbers below, not advice. Score +0 (DCF counts double).
▼DCF (base case)below the price by 32%
▲Piotroski F-score8/9
▲Altman Z5.8 (safe)
▲Net debt / EBITDA-1.8x
▲Analyst target+81% (3 analysts)
Discounted cash flow
Bear
$10
-48%
growth 0% · disc. 13.6% · term. 2.0%
Base
$13
-32%
growth 5% · disc. 12.6% · term. 2.5%
Bull
$16
-13%
growth 8% · disc. 11.6% · term. 3.0%
A DCF starts from trailing free cash flow, so it can overstate value if the last 12 months were unusually strong (or weak). Use the bear case or edit the starting cash flow if so.
Reverse DCFfor context, not a signal
A normal DCF guesses future cash flows and works out a price. A reverse DCF runs it backwards: it starts from today's price and asks how fast free cash flow would have to grow to justify it. It tells you what the market is assuming, not whether the stock is cheap or expensive, and it is not a buy or sell signal. Glossary
Today's price assumes free cash flow grows about 12% a year for 10 years.
Implied
+12%/yr
FCF, last 3 yrs
n/a
FCF, last 5 yrs
-10%/yr
Revenue, last 3 yrs
+4%/yr
Revenue, last 5 yrs
+12%/yr
Same inputs as the DCF above: trailing free cash flow 0.0B, 12.6% discount rate, 2.5% growth after year 10, net cash and today's share count. Actual growth rates are compound annual rates from SEC annual filings through FY2026; "n/a" means too little history or a negative starting year.
Edit assumptions · recalculates instantly
Your value per share–
Free cash flow = operating cash flow − capital spending, trailing 12 months (TTM to 2026-08-01). Growth default: average of 3-year revenue CAGR and latest revenue growth, capped at 30%. Years 6–10 fade linearly to terminal growth. Discount rate = 4.25% risk-free assumption + beta 1.68 × 5% equity premium, kept within 7–13%. Bear: lower growth, +1 pt discount, 2% terminal. Bull: higher growth, −1 pt, 3%.
Multiples vs sector
Forward EPS $1.58 vs trailing $0.98 (+61% expected growth). Forward P/E uses analysts' next-12-month estimate.
Backlog (remaining performance obligations)
RPO
$380.4M
as of 2026-08-01
vs a year ago
-11%
YoY
× TTM revenue
0.45×
coverage
Contracted revenue not yet recognized, from SEC filings (XBRL tag RevenueRemainingPerformanceObligation).
Quality & financial health
Gross margin
27.6%
Operating margin
7.3%
FCF margin
4.7%
Net margin
5.7%
Return on equity
15.2%
Return on invested capital
28.2%
Net debt / EBITDA
-1.8×
Current ratio
2.2×
Interest cover
42.7×
Cash conversion (OCF/NI)
1.1×
Piotroski F-score 8/9 · last two fiscal years
✓ Positive net income✓ Positive operating cash flow✓ Return on assets improved✓ Cash flow above net income✓ Long-term debt / assets fell✓ Current ratio improved✗ No share dilution✓ Gross margin improved✓ Asset turnover improved
Altman Z-score 5.8 (safe zone; above 3.0 = safe, below 1.8 = distress). Not meaningful for banks and insurers.
Analysts
Mean target
$34
+81%
Analysts
3
Strong Buy
Range
$29–$39
low – high
● price · ◆ mean target
Annual history
| FY | Revenue | Net income | Free cash flow |
|---|---|---|---|
| 2026 | $838.7M | $45.4M | $34.3M |
| 2025 | $756.5M | $-10.1M | $78.2M |
| 2024 | $818.1M | $34.6M | $46.3M |
| 2023 | $754.2M | $6.8M | $-10.4M |
| 2022 | $611.0M | $592.0K | $-47.4M |
| 2021 | $482.0M | $10.9M | $58.3M |
From the company's 10-K filings via SEC XBRL. 3-year revenue CAGR +3.6%.
Earnings
Next report: 2026-12-09 · before open · EPS est 0.31
EstimateActual (beat)Actual (miss)
| Report | EPS est | Actual | Surprise |
|---|---|---|---|
| 2026-06-24 | 0.15 | 0.27 | +78.3% |
| 2026-03-04 | 0.13 | 0.09 | -28.9% |
| 2025-12-10 | 0.27 | 0.35 | +32.1% |
| 2025-09-10 | 0.21 | 0.33 | +57.1% |
| 2025-06-25 | 0.14 | 0.18 | +22.2% |
| 2025-03-05 | 0.08 | 0.01 | -85.8% |
| 2024-12-04 | 0.20 | 0.27 | +34.8% |
| 2024-09-04 | 0.30 | 0.36 | +19.8% |
Quarterly revenue
| Quarter | Revenue | YoY |
|---|---|---|
| 2026-07-31 | $234.6M | +7.1% |
| 2026-04-30 | $208.6M | – |
| 2026-01-31 | $181.9M | – |
| 2025-10-31 | $229.3M | – |
| 2025-07-31 | $219.0M | – |
Analyst actions
Roth Capital
PT $29
2026-07-02 · main
Buy → BuyPT $29
Roth Capital
PT $26
2026-06-11 · init
→ BuyPT $26
Craig-Hallum
PT $26
2025-01-22 · init
→ BuyPT $26
Singular Research
PT $10
2018-09-21 · main
Buy → BuyPT $10
Singular Research
PT $14
2016-12-19 · init
→ BuyPT $14
Needham
2015-09-23 · up
Hold → BuyRecent dividends
2020-03-06: $0.050 · 2019-12-13: $0.050 · 2019-09-13: $0.050 · 2019-06-07: $0.050 · 2019-03-08: $0.070 · 2018-12-07: $0.070 · 2018-09-14: $0.070 · 2018-06-08: $0.070
Insider trades
Wiemann Bradley T
$76.9K
Executive Vice President · 2026-07-17
SELL$76.9K
None
–
None · None
SELL–
None
–
None · None
SELL–
None
–
None · None
SELL–
None
–
None · None
SELL–
None
–
None · None
SELL–
None
–
None · None
SELL–
None
–
None · None
SELL–
None
–
None · None
SELL–
None
–
None · None
SELL–
None
–
None · None
SELL–
None
–
None · None
SELL–
News
Zacks.com featured highlights include Jabil, Daktronics, Motorsport Games and Shinhan Financial
Zacks · 16h ago
4 Stocks With Robust Net Profit Margins to Enrich Your Portfolio
Zacks · Oct 16
Daktronics to Close Ireland Factory in Restructuring Saving $18 Million a Year
MT Newswires · Oct 14
Daktronics Announces Implementation Actions for Strategic Structural Cost Reduction and Manufacturing Optimization
GlobeNewswire · Oct 14
Wall Street Analysts Think Daktronics (DAKT) Could Surge 77.68%: Read This Before Placing a Bet
Zacks · Oct 12
DAKT vs. GRMN: Which Stock Is the Better Value Option?
Zacks · Oct 05
Should Value Investors Buy Daktronics (DAKT) Stock?
Zacks · Oct 05
SMCAY Rides on Healthy Semiconductor Demand Trends: Should You Buy?
Zacks · Sep 28
Stats refreshed 2026-10-19 19:02:37 ET from Yahoo Finance (yfinance). "–" means the data isn't available. Refresh now
coteau
Coteau Systematic StrategiesSystematic equity research and model portfolios.Coteau Systematic Strategies publishes research, model portfolios and tools. It does not manage money or offer investment advice. Model results are hypothetical. Data: Yahoo Finance (delayed), SEC EDGAR.